For the active immunisation of female pigs for the protection of progeny against transplacental infection caused by porcine parvovirus. For the active immunisation of male and female pigs to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by Erysipelothrix rhusiopathiae, serotype 1 and serotype 2. Onset of immunity: Porcine parvovirus: from the beginning of the gestation period. E.rhusiopathiae: three weeks after completion of the basic vaccination scheme. Duration of immunity: Porcine parvovirus: vaccination provides foetal protection for the duration of gestation. Revaccination should be performed prior to each gestation, refer to section “Dosage for each species, route(s) and method of administration”. E. rhusiopathiae: vaccination protects against swine erysipelas until the time of the recommended revaccination (approximately six months after the basic vaccination scheme)
